Acute endothelin-receptor inhibition does not attenuate acetylcholine- induced coronary vasoconstriction in experimental hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 1, 1998, Pages 108-113

  Hasdai, David ^a   Best, Patricia J M ^a   Cannan, Charles R ^a   Mathew, Verghese ^a   Schwartz, Robert S ^a   Holmes Jr , David R ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acetylcholine; Endothelin; Endothelin receptor; Hypercholesterolemia; Pig

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ACETYLCHOLINE; BOSENTAN; CHOLESTEROL; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; SARAFOTOXIN;

ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; HEMODYNAMICS; HYPERCHOLESTEROLEMIA; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0031984704     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.1.108     Document Type: Article

References (15)

1. Levin ER. Endothelins. N Engl J Med. 1995;333:356-363.
2. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelial receptor. Nature. 1990;348:730-732.
3. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki M. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990;348:732-735.
4. Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun. 1993;191:1081-1088.
5. Cannan CR, Burnett JC Jr. Brandt RR, Lerman A. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor. Circulation. 1995;92:3312-3317.
6. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and acute coronary syndromes (part I). N Engl J Med. 1992;326:242-250.
7. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau V. Impaired vasodilation of forearm vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
8. Lerman A, Webster MW, Chesebro JH, Edwards WD, Wei CM, Fuster V, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation. 1993;88:2923-2928.
9. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 1995;92:2426-2431.
10. Cardell LO, Uddman R, Edvinsson L. A novel ETA-receptor antagonist, FR 139317, inhibits endothelin-induced contractions of guinea-pig pulmonary arteries, but not trachea. Br J Pharmacol. 1993;108:448-452.
11. Lopez JA, Armstrong ML, Piegors DJ, Heistad DD. Vascular responses to endothelin-1 in atherosclerotic primates. Atherosclerosis. 1990;161:803-808.
12. Teerlink JR, Loffler BM, Hess P, Maire JP, Clozel M, Clozel JP. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure:, acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). Circulation. 1994;90:2510-2518.
13. Allain CC, Poon LS, Chan CSL, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
14. Erikson JM, Velasco CE. Endothelin-1 and myocardial preconditioning. Am Heart J. 1996;132:84-90.
15. Bove AA, Holmes DR Jr, Owen RM, Bresnahan JF, Reeder GS, Smith HC, Vlietstra RE. Estimation of the effects of angioplasty on coronary stenosis using quantitative video angiography. Cathet Cardiovosc Diagn. 1985;11:5-16.